down arrow

Milestone Scientific, Inc.

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US59935P2092
USD
0.35
0 (1.37%)

Dec 04

ASE

 Click here to see other stocks
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

0.310.35

52 Week

0.281.39
Valuation
Technical
Day's Volume

CASH

301.67 k

Shareholding (Mar 2025)

FII

0.14%

Held by 7 FIIs

DII

95.86%

Held by 4 DIIs

Promoter

0.00%

How big is Milestone Scientific, Inc.?

22-Jun-2025

As of Jun 18, Milestone Scientific, Inc. has a market capitalization of 67.91 million, with recent net sales of 8.60 million and a net loss of 5.27 million for the four quarters ending in March 2025. As of December 2024, shareholder's funds were 5.83 million, and total assets were 9.80 million.

Market Cap: As of Jun 18, Milestone Scientific, Inc. has a market capitalization of 67.91 million, categorizing it as a Micro Cap company.<BR><BR>Recent Quarterly Performance: For the latest four quarters ending in March 2025, the company reported net sales of 8.60 million. During the same period, the consolidated net profit was a loss of 5.27 million.<BR><BR>Balance Sheet Snapshot: As of December 2024, the shareholder's funds amounted to 5.83 million, while total assets were reported at 9.80 million.

Read More

What does Milestone Scientific, Inc. do?

22-Jun-2025

Milestone Scientific, Inc. develops computer-controlled injection technologies for the medical and dental sectors, operating as a micro-cap company with a market cap of approximately $67.91 million. As of March 2025, it reported net sales of $2 million and a net loss of $2 million.

Overview: <BR>Milestone Scientific, Inc. is engaged in providing computer-controlled injection technologies and solutions for the medical and dental markets within the Pharmaceuticals & Biotechnology industry, classified as a micro-cap company.<BR><BR>Financial Snapshot: <BR>Most recent Net Sales: 2 Million (Quarterly Results - Mar 2025) <BR>Most recent Net Profit: -2 Million (Quarterly Results - Mar 2025) <BR>Market-cap: USD 67.91 Million (Micro Cap)<BR><BR>Key Metrics: <BR>P/E: NA (Loss Making) <BR>Industry P/E: NA <BR>Dividend Yield: 0.00% <BR>Debt Equity: -0.47 <BR>Return on Equity: -118.04% <BR>Price to Book: 15.22<BR><BR>Contact Details: <BR>Address: 220 S Orange Ave, LIVINGSTON NJ: 07039-5804 <BR>Tel: 1 973 5352717 <BR>Fax: 1 973 5352829 <BR>Website: https://www.milestonescientific.com/

Read More

Who are in the management team of Milestone Scientific, Inc.?

22-Jun-2025

As of March 2022, the management team of Milestone Scientific, Inc. includes Ms. Leslie Bernhard (Independent Non-Executive Chairman), Mr. Leonard Osser (Director), Mr. Gian Trombetta (Director), Mr. Neal Goldman (Independent Director), and Mr. Michael McGeehan (Independent Director). They are responsible for the company's strategic direction and governance.

As of March 2022, the management team of Milestone Scientific, Inc. includes the following individuals:<BR><BR>- Ms. Leslie Bernhard, who serves as the Independent Non-Executive Chairman of the Board.<BR>- Mr. Leonard Osser, who is a Director.<BR>- Mr. Gian Trombetta, also a Director.<BR>- Mr. Neal Goldman, who is an Independent Director.<BR>- Mr. Michael McGeehan, another Independent Director. <BR><BR>This team plays a crucial role in guiding the company's strategic direction and governance.

Read More

Is Milestone Scientific, Inc. technically bullish or bearish?

20-Sep-2025

As of September 10, 2025, Milestone Scientific, Inc. is in a bearish trend with weak strength, indicated by bearish signals from daily moving averages, weekly KST, and OBV, while significantly underperforming the S&P 500 with year-to-date and 1-year returns of -43.98% and -40.02%, respectively.

As of 10 September 2025, the technical trend for Milestone Scientific, Inc. has changed from mildly bearish to bearish. The current stance is bearish with weak strength, indicated by the daily moving averages and the weekly KST and OBV both showing bearish signals. The MACD is mildly bullish on the weekly but bearish on the monthly, which adds to the mixed signals. The Bollinger Bands are bearish on both weekly and monthly time frames. <BR><BR>In terms of performance, the stock has significantly underperformed compared to the S&P 500 across multiple periods, with a year-to-date return of -43.98% versus the S&P 500's 12.22%, and a 1-year return of -40.02% compared to 17.14% for the index.

Read More
iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard
Icon
Unrated Stock - No Analysis Available
stock-summaryMojo Parameters
Mojo Parameters
Stock DNA
stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

USD 48 Million (Micro Cap)

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.10

stock-summary
Return on Equity

-208.80%

stock-summary
Price to Book

14.26

Revenue and Profits:
Net Sales:
2 Million
(Quarterly Results - Jun 2025)
Net Profit:
-1 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-43.76%
0%
-43.76%
6 Months
-61.63%
0%
-61.63%
1 Year
-57.44%
0%
-57.44%
2 Years
-55.82%
0%
-55.82%
3 Years
-48.68%
0%
-48.68%
4 Years
-82.64%
0%
-82.64%
5 Years
-81.24%
0%
-81.24%

Milestone Scientific, Inc. for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions
News

Is Milestone Scientific, Inc. technically bullish or bearish?

As of 10 September 2025, the technical trend for Milestone Scientific, Inc. has changed from mildly bearish to bearish. The current stance is bearish with weak strength, indicated by the daily moving averages and the weekly KST and OBV both showing bearish signals. The MACD is mildly bullish on the weekly but bearish on the monthly, which adds to the mixed signals. The Bollinger Bands are bearish on both weekly and monthly time frames. In terms of performance, the stock has significantly underperformed compared to the S&P 500 across multiple periods, with a year-to-date return of -43.98% versus the S&P 500's 12.22%, and a 1-year return of -40.02% compared to 17.14% for the index....

Read More
Announcements stock-summary
Icon
No announcement available
Corporate Actions stock-summary
Icon
No corporate action available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
8.00%
EBIT Growth (5y)
-0.41%
EBIT to Interest (avg)
-7.58
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.47
Sales to Capital Employed (avg)
1.36
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
6.10%
ROCE (avg)
0
ROE (avg)
0
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
16.05
EV to EBIT
-9.54
EV to EBITDA
-9.73
EV to Capital Employed
29.55
EV to Sales
8.07
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-309.83%
ROE (Latest)
-118.04%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Bearish
Dow Theory
No Trend
Mildly Bearish
OBV
No Trend
Mildly Bearish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Mar 2025stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Domestic Funds

Domestic Funds

Held in 5 Schemes (4.0%)

Foreign Institutions

Held by 7 Foreign Institutions (0.14%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Jun 2025 is 4.55% vs 10.00% in Mar 2025",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Jun 2025 is 25.00% vs 0.00% in Mar 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Jun'25",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "2.30",
          "val2": "2.20",
          "chgp": "4.55%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-1.40",
          "val2": "-2.00",
          "chgp": "30.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-1.50",
          "val2": "-2.00",
          "chgp": "25.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-639.00%",
          "val2": "-894.90%",
          "chgp": "25.59%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is -12.24% vs 11.36% in Dec 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is 32.86% vs 20.45% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "8.60",
          "val2": "9.80",
          "chgp": "-12.24%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-6.60",
          "val2": "-7.00",
          "chgp": "5.71%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-4.70",
          "val2": "-7.00",
          "chgp": "32.86%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-783.00%",
          "val2": "-723.10%",
          "chgp": "-5.99%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQstock-summary
Jun'25
Mar'25
Change(%)
Net Sales
2.30
2.20
4.55%
Operating Profit (PBDIT) excl Other Income
-1.40
-2.00
30.00%
Interest
0.00
0.00
Exceptional Items
0.00
0.00
Consolidate Net Profit
-1.50
-2.00
25.00%
Operating Profit Margin (Excl OI)
-639.00%
-894.90%
25.59%
USD in Million.
stock-summary Compare with Peers
Direction Arrows
Net Sales

QoQ Growth in quarter ended Jun 2025 is 4.55% vs 10.00% in Mar 2025

Direction Arrows
Consolidated Net Profit

QoQ Growth in quarter ended Jun 2025 is 25.00% vs 0.00% in Mar 2025

All Quarterly Resultsstock-summary
Annual Results Snapshot (Consolidated) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
8.60
9.80
-12.24%
Operating Profit (PBDIT) excl Other Income
-6.60
-7.00
5.71%
Interest
0.00
0.00
Exceptional Items
0.00
0.00
Consolidate Net Profit
-4.70
-7.00
32.86%
Operating Profit Margin (Excl OI)
-783.00%
-723.10%
-5.99%
USD in Million.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in year ended Dec 2024 is -12.24% vs 11.36% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2024 is 32.86% vs 20.45% in Dec 2023

All Annual Resultsstock-summary
stock-summaryCompany CV
About Milestone Scientific, Inc. stock-summary
stock-summary
Milestone Scientific, Inc.
Pharmaceuticals & Biotechnology
Milestone Scientific Inc. (Milestone) is engaged in providing computer-controlled injection technologies and solutions for the medical and dental markets. The Company uses its CompuFlo technology for the delivery of medicaments. The CompuFlo pressure or force Computer-Controlled Local Anesthetic Delivery (C-CLAD) technology is a medical technology for the delivery of drugs, anesthetics and other medicaments into various tissue types. Milestone's product portfolio includes Single Tooth Anesthesia Instrument (STA Instrument), CompuDent, CompuMed and The Wand. The Company's STA Instrument is a computer-controlled local anesthesia delivery instrument that utilizes the pressure feedback elements of Milestone's CompuFlo technology. CompuDent (also known as the Wand Plus internationally) is Milestone's C-CLAD instrument. CompuMed is a computer-controlled injection instrument offered by the Company. The Wand handpiece is used in conjunction with the STA, CompuDent and CompuMed instruments.
Company Coordinates stock-summary
Company Details
220 S Orange Ave , LIVINGSTON NJ : 07039-5804
stock-summary
Tel: 1 973 5352717
stock-summary
https://www.milestonescientific.com/
stock-summary
Registrar Details
Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."